Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study

NCT00630786 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
53
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen